BSE Live
Dec 05, 16:01Prev. Close
344.75
Open Price
348.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:55Prev. Close
347.20
Open Price
349.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
344.15 (84)
| Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | |
| Total Share Capital | 9.02 | 16.67 | 15.59 | 14.61 | 22.43 | |
| Reserves and Surplus | 832.82 | 402.71 | 372.33 | 440.06 | 517.60 | |
| Total Reserves and Surplus | 832.82 | 402.71 | 372.33 | 440.06 | 517.60 | |
| Total Shareholders Funds | 873.84 | 419.38 | 387.92 | 454.67 | 540.03 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 57.54 | 77.76 | 561.25 | 705.57 | 778.88 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 2.14 | 0.68 | 4.29 | 4.77 | 0.34 | |
| Long Term Provisions | 12.56 | 13.49 | 25.12 | 17.20 | 14.18 | |
| Total Non-Current Liabilities | 72.24 | 91.93 | 590.66 | 727.54 | 793.40 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 3.57 | 69.39 | 193.82 | 219.65 | 218.25 | |
| Trade Payables | 135.90 | 77.88 | 241.84 | 226.75 | 173.83 | |
| Other Current Liabilities | 28.50 | 771.63 | 242.82 | 142.05 | 80.55 | |
| Short Term Provisions | 2.65 | 2.19 | 6.79 | 1.45 | 1.37 | |
| Total Current Liabilities | 170.62 | 921.09 | 685.27 | 589.91 | 474.00 | |
| Total Capital And Liabilities | 1,138.49 | 1,442.04 | 1,673.49 | 1,781.75 | 1,807.43 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 446.26 | 494.87 | 886.56 | 936.08 | 976.19 | |
| Intangible Assets | 1.03 | 1.57 | 4.37 | 5.94 | 11.39 | |
| Capital Work-In-Progress | 3.66 | 2.95 | 4.76 | 5.98 | 8.65 | |
| Other Assets | 51.99 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 503.02 | 499.54 | 928.09 | 969.70 | 1,006.59 | |
| Non-Current Investments | 2.55 | 2.54 | 344.88 | 344.88 | 394.66 | |
| Deferred Tax Assets [Net] | 1.45 | 19.20 | 21.99 | 31.87 | 0.00 | |
| Long Term Loans And Advances | 1.12 | 0.63 | 0.99 | 0.99 | 66.82 | |
| Other Non-Current Assets | 16.05 | 4.01 | 23.89 | 24.94 | 0.55 | |
| Total Non-Current Assets | 524.17 | 525.93 | 1,319.84 | 1,372.38 | 1,468.62 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 99.23 | 42.51 | 149.10 | 140.60 | 136.57 | |
| Trade Receivables | 17.69 | 25.20 | 142.27 | 175.80 | 142.21 | |
| Cash And Cash Equivalents | 60.61 | 7.85 | 11.79 | 7.21 | 9.32 | |
| Short Term Loans And Advances | 1.13 | 16.20 | 14.99 | 10.32 | 45.36 | |
| OtherCurrentAssets | 435.67 | 824.35 | 35.51 | 75.44 | 5.35 | |
| Total Current Assets | 614.32 | 916.11 | 353.65 | 409.37 | 338.81 | |
| Total Assets | 1,138.49 | 1,442.04 | 1,673.49 | 1,781.75 | 1,807.43 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 368.16 | 407.73 | 428.11 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 79.67 | 26.59 | 90.77 | 49.06 | 59.07 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.30 | 0.11 | 1.82 | 5.79 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 6.78 | 19.22 | 20.08 | 21.84 | 30.59 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 145.96 | 95.39 | 142.43 | 183.17 | 234.81 | |
| Other Earnings | 11.38 | 24.92 | 17.58 | 16.65 | 34.96 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 2.55 | 2.54 | 344.88 | 344.88 | 394.66 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y